跳至主要内容
临床试验/DRKS00027410
DRKS00027410已完成不适用

Optimising polypharmacotherapy in geriatric patients with the medication review software Medinspector - OPtiMed

Viandar GmbH0 个研究点目标入组 148 人开始时间: 2021年12月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • age = 65 years
  • - permanent intake of = 5 active pharmaceutical substances with systemic effects (combinations of active ingredients in phytotherapeutics and homeopathics are counted as a single active substance)
  • - written informed consent
  • - completed software-assisted medication review

排除标准

  • - For patients with more than one completed medication review in the recruitment period, only the first analysis will be considered.
  • - The inclusion of patients per pharmacy is limited to a maximum of 15% of the calculated samplze size (n = 148), which corresponds to 22 patients per pharmacy.

研究者

发起方
Viandar GmbH

相似试验